Bio-Techne (TECH) announced the launch of an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation ...

Baird analyst Catherine Ramsey Schulte downgraded Bio-Techne (TECH) to Neutral from Outperform with a price target of $68, down from $88. The firm has concerns around the future of National ...

and Africa, Greater China, rest of Asia-Pacific, and internationally. Receive News & Ratings for Bio-Techne Daily - Enter your email address below to receive a concise daily summary of the latest ...

MINNEAPOLIS, Feb. 18, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools, is pleased to announce the official release of GMP ...

Shares of Bio-Techne Corporation (NASDAQ:TECH) traded higher after the life sciences company topped analysts' expectations with its Q2 FY25 results, indicating a faster topline growth amid early ...

Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (TECH) is a leading provider of life sciences solutions dedicated to advancing biomedical research and diagnostics. With a market ...

MINNEAPOLIS (AP) — MINNEAPOLIS (AP) — Techne Corp. (TECH) on Wednesday reported fiscal second-quarter earnings of $34.9 million. On a per-share basis, the Minneapolis-based company said it had ...

Feb 5 (Reuters) - Bio-Techne (TECH.O), opens new tab beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop ...

Bio-Techne delivered strong Q2 results, with 9% organic revenue growth driven by biopharma recovery, operational efficiencies, and robust product portfolios. Management maintained confidence in ...

(RTTNews) - Bio-Techne Corp. (TECH) announced earnings for its second quarter that increased from last year and beat the Street estimates. The company's bottom line totaled $34.89 million ...

JOHANNESBURG, Feb 17 (Reuters) - South Africa's foreign minister Ronald Lamola said on Monday that the United States had not responded to attempts to discuss President Donald Trump's executive ...